The following drug candidates are out of the scope:
- Known substances with poor exclusivity
- Development candidates whose phase II study has been completed in subjects with the target diseases
Anticipated Project Phases or Project Plan
Respondents should submit proposals using the attached Response Template.
The client will review submitted proposals and possibly ask clarifying questions before selecting the most suitable candidates for collaboration. The client will select the best candidate(s) through evaluations. During the selection process, the client may execute non-disclosure agreements (NDA) with selected respondent(s), seek further information disclosure, and discuss specific development targets or potential opportunities.
The client will execute necessary agreement(s) with the selected respondent(s) and move to the advanced development phase. Specifics of any collaboration will be determined through consultation with the concerned parties.